Close Menu

NEW YORK – While BRCA mutations are key events in the development of some tumors, they are likely passenger mutations in others — a finding with likely treatment implications, according to a new analysis conducted by researchers led by a team from Memorial Sloan Kettering Cancer Center.

To read the full story....

...and receive Weekly News bulletins.

Already have a Precision Oncology News or 360Dx or GenomeWeb account?
Login Now.

Don't have a Precision Oncology News or 360Dx or GenomeWeb account?
Register for Free.